Considering the close relationships among age, obesity, and immune balances, we preferred to believe the immune intervening method, taking TNF-α inhibitors as the typical example, would provide new insight into the treatment of OSA. Here, TNF is linked to obesity due to melanocortin 4 receptor deficiency.